Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials. Flanders MD, Caunca M, La Joie R, Schneider LS, et al. JAMA Neurol 2026 May 18:e261240. doi: 10.1001/jamaneurol.2026.1240.

Read + Share

Amedeo Smart

Independent Medical Education

Flanders MD, Caunca M, La Joie R, Schneider LS, et al. Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials. JAMA Neurol 2026 May 18:e261240. doi: 10.1001/jamaneurol.2026.1240.
PMID: 42149605